Press Release: Paladin Labs : Paladin Labs Announced Favourable CADTH Recommendation for XCOPRI (cenobamate tablets)
/CNW/ -- Paladin Labs Inc. announced today that the Canadian Agency for Drugs and Technologies in Health (CADTH) recommended that XCOPRI (cenobamate tablets)...
Read full article »
Paladin Labs is a pharmaceutical company focused on developing, acquiring, in-licensing, marketing and distributing pharmaceutical products.
Read more